Canada must ensure all orphan drugs are priced fairly to allow patient access

In developing an orphan drug policy, Canada must ensure that all orphan drugs for rare diseases — both old and future drugs — should be priced fairly so that Canadians may access life-saving therapy, argue authors of a new Canadian analysis. —> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *